Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.
Wang P, Jia X, Lu B, Huang H, Liu J, Liu X, Wu Q, Hu Y, Li P, Wei H, Liu T, Zhao D, Zhang L, Tian X, Jiang Y, Qiao Y, Nie W, Ma X, Bai R, Peng C, Dong Z, Liu K.
Wang P, et al. Among authors: lu b.
Signal Transduct Target Ther. 2023 Mar 6;8(1):96. doi: 10.1038/s41392-023-01329-3.
Signal Transduct Target Ther. 2023.
PMID: 36872366
Free PMC article.